Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,315.60
-33.85 (-2.51%)
At close: Aug 17, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 9.07 billion as of August 17, 2026. Its market cap has decreased by -7.33% in one year.
Market Cap
9.07B
Enterprise Value
10.25B
Revenue
3.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,315.60
ChartMarket Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 9.07B, an increase of 891.53%. That is a compound annual growth rate of 31.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 9.07B | 8.78% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 14.30B |
| Syncom Formulations (India) | 14.02B |
| Fermenta Biotech | 12.88B |
| Lincoln Pharmaceuticals | 12.28B |
| Kopran | 9.18B |
| Wanbury | 9.13B |
| Sudarshan Pharma Industries | 8.74B |
| Hexagon Nutrition | 7.86B |